logo

APGE

Apogee Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

APGE fundamentals

Apogee Therapeutics (APGE) released its earnings on Nov 10, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -1.11 (YoY -29.07%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-1.11
-29.07%
Report date
Nov 10, 2025
EPS
Revenue

Revenue & Expenses

Key Indicators

Apogee Therapeutics (APGE) key financial stats and ratios, covering profitability, financial health, and leverage.
Apogee Therapeutics (APGE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Apogee Therapeutics (APGE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Apogee Therapeutics (APGE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Apogee Therapeutics (APGE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Apogee Therapeutics (APGE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield